Martine Kruijtbosch

132 Chap t e r 3. 3 TABLE 3: Association between the likelihood of nine intended actions and pharmacists with and without dominant PE-MRPs in three drug shortage scenarios (267 pharmacists) Intended action in three drug shortage scenarios Pharmacists with dominant PE-MRPs Pharmacists without dominant PE-MRPs Odds ratio a n (%) n (%) (95% CI) 1. I would likely explain to the patient that I cannot dispense the medicine due to its shortage Osteoporosis (low impact on patient outcomes) 167/199 (83.9) 59/68 (86.8) 0.80 (0.36–1.77) Contraceptive (medium impact on patient outcomes) 119/164 (72.6) 78/103 (75.7) 0.85 (0.48–1.49) Parkinson’s (high impact on patient outcomes) 156/212 (73.6) 46/55 (83.6) 0.54 (0.25–1.18) 2. I would likely refer the patient to the prescriber for possible alternative (pharmaceutical) treatments Osteoporosis (low impact on patient outcomes) 52/199 (26.1) 19/68 (27.9) 0.91 (0.49–1.69) Contraceptive (medium impact on patient outcomes) 61/164 (37.2) 46/103 (44.7) 0.73 (0.44–1.21) Parkinson’s (high impact on patient outcomes) 82/212 (38.7) 22/55 (40.0) 0.95 (0.52–1.73) 3. I would likely propose a possible alternative pharmaceutical treatment to the prescriber Osteoporosis (low impact on patient outcomes) 186/199 (93.5) 63/68 (92.6) 1.14 (0.39–3.31) Contraceptive (medium impact on patient outcomes) 148/164 (90.2) 91/103 (88.3) 1.22 (0.55–2.69) Parkinson’s (high impact on patient outcomes) 190/212 (89.6) 52/55 (94.5) 0.50 (0.14–1.73 4. I would likely discuss possible alternative pharmaceutical treatments with the patient Osteoporosis (low impact on patient outcomes) 182/199 (91.5) 62/68 (91.2) 1.04 (0.39–2.74) Contraceptive (medium impact on patient outcomes) 148/164 (90.2) 94/103 (91.3) 0.89 (0.38–2.09) Parkinson’s (high impact on patient outcomes) 186/212 (87.7) 43/55 (78.2) 2.00 (0.93–4.27) 5. I would likely import the medicine of which there is a shortage Osteoporosis (low impact on patient outcomes) 36/199 (18.1) 18/68 (26.5) 0.61 (0.32–1.17) Contraceptive (medium impact on patient outcomes) 102/164 (62.2) 61/103 (59.2) 1.13 (0.68–1.87) Parkinson’s (high impact on patient outcomes) 169/212 (79.7) 31/55 (56.4) 3.04 (1.62–5.71) 6. I would likely have made agreements in advance with the prescribers in my area related to alternatives for this drug shortage Osteoporosis (low impact on patient outcomes) 141/199 (70.9) 47/68 (69.1) 1.09 (0.60–1.98) Contraceptive (medium impact on patient outcomes) 137/164 (83.5) 77/103 (74.8) 1.71 (0.93–3.14) Parkinson’s (high impact on patient outcomes) 123/212 (58.0) 25/55 (45.5) 1.66 (0.91–3.01)